Cumberland Pharmaceuticals Inc. Stock News

Translate Bio (TBIO) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Cumberland Pharmaceuticals (NASDAQ:CPIX) and Merus (NASDAQ:MRUS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) Arcutis Biotherapeutics...

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company, today announced a national initiative to support the treatment of patients with hospital-acquired and ventilato

Ariel Investments' 13F portfolio value increased from $7.51B to $7.97B this quarter. It increased Nielsen Holdings while dropping Thermo Fisher Scientific durin

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced fourth quarter and full year 2019 financial resu

Companies Reporting Before The Bell General Mills, Inc. (NYSE: GIS ) is expected to report quarterly earnings at $0.77 per share on revenue of $4.23 billion. Qudian Inc. (NYSE: QD ) is estimated to re

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) …

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced topline results from a clinical study evaluating the safety and pharmacokinetics of Caldolor® (ibuprofen) Injection in children ranging

The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either. Biogen Inc (NASDAQ: BIIB ) was in the news for all wrong reasons, as an employee confere

The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either. Biogen Inc (NASDAQ: BIIB) was in the news for all wrong...